GEISTWERT Rechtsanwälte Lawyers Avvocati

ORD_27388/2025

Sanofi Biotechnology SAS, Regeneron Pharmaceuticals Inc.

Datum
2025-08-06
Kammer
Düsseldorf (DE) Local Division
Verfahrensart
Generic application
Sprache
EN

Metadaten

Fall-IDORD_27388-2025-59185b9011b1
Aktenzeichen
RegisterzeichenORD_27388/2025
EntscheidungsreferenzORD_27388/2025
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 4

1 Düsseldorf Local Division UPC_CFI_195/2025 Procedural Order of the Court of First Instance of the Unified Patent Court issued on 6 August 2025 concerning EP 4 252 857 CLAIMANTS: 1. Sanofi Biotechnologies SAS, 82 avenue Raspail, 94250 Gentily , France, represented by its chairman, Laurent Gilhodes, 2. Regeneron Pharmaceuticals Inc., 777 Old Saw Mill River Road, Tarrytown, New York 10591, United States of America, represented by its CEO Leonard Schleifer, all Claimants represented by: Dr. Niel s Hölder, Mike Gruber, Dr. Michael Pfeifer and all other UPC Represenatives of HOFFMANN EITLE PartmbB, Daniel Wise, Agathe Michel-de Cazotte and all other UPC Rep- resentatives of CARPMEALS & RANSFORD, 1 Southampton Row WC1B 5HA London, United Kingdom, electronic address for service: nhoelder@hoffman ...